Sangamo Therapeutics
SGMO
SGMO
210 hedge funds and large institutions have $919M invested in Sangamo Therapeutics in 2018 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 95 increasing their positions, 48 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
+2
Holders Change %
+0.96%
% of All Funds
4.81%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.05%
New
38
Increased
95
Reduced
48
Closed
34
Calls
$27.1M
Puts
$29.6M
Net Calls
-$2.51M
Net Calls Change
+$8.4M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$86.3M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
$21.4M |
| 3 |
BlackRock
New York
|
$115M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$116M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
$46.2M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$47.1M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
$151K |
| 3 |
Invesco
Atlanta,
Georgia
|
$8.12M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$19K |
| 5 |
Morgan Stanley
New York
|
$13M |
